Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omnitram vs Tramadol in CYP2D6-deficient Healthy Subjects
NCT03312777Phase 1Completed
- Sponsor
- Syntrix Pharmaceuticals
- Start
- Oct 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of desmetramadol in pain, sponsored by Syntrix Pharmaceuticals. Primary endpoint: Cold Pressor Test - Cold Water Induced-Pain. Started Oct 2017; status: completed.
02
Drugs
desmetramadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT03312777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03312777.